N/A
Manufactured by Chartwell RX, LLC
267 FDA adverse event reports analyzed
Last updated: 2026-04-15
CHLORDIAZEPOXIDE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chartwell RX, LLC. The most commonly reported adverse reactions for CHLORDIAZEPOXIDE HYDROCHLORIDE include DRUG INEFFECTIVE, DIZZINESS, FATIGUE, HEADACHE, BACK PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORDIAZEPOXIDE HYDROCHLORIDE.
Out of 102 classified reports for CHLORDIAZEPOXIDE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 267 FDA FAERS reports that mention CHLORDIAZEPOXIDE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, DIZZINESS, FATIGUE, HEADACHE, BACK PAIN, COMPLETED SUICIDE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Chartwell RX, LLC in connection with CHLORDIAZEPOXIDE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.